| 产品编号 | CFN91726 | |
| CAS编号 | 60-18-4 | |
| 分子式 = 分子量 | C9H11NO3 = 181.19 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | From Chemical synthesis | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| L-酪氨酸 | CFN91726 | 60-18-4 | 10mg | QQ客服:1457312923 |
| L-酪氨酸 | CFN91726 | 60-18-4 | 20mg | QQ客服:1457312923 |
| L-酪氨酸 | CFN91726 | 60-18-4 | 50mg | QQ客服:1457312923 |
| L-酪氨酸 | CFN91726 | 60-18-4 | 100mg | QQ客服:1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex. IC50 & Target: Microbial Metabolite; Human Endogenous Metabolite |
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.5191 mL | 27.5953 mL | 55.1907 mL | 110.3814 mL | 137.9767 mL |
| 5 mM | 1.1038 mL | 5.5191 mL | 11.0381 mL | 22.0763 mL | 27.5953 mL |
| 10 mM | 0.5519 mL | 2.7595 mL | 5.5191 mL | 11.0381 mL | 13.7977 mL |
| 50 mM | 0.1104 mL | 0.5519 mL | 1.1038 mL | 2.2076 mL | 2.7595 mL |
| 100 mM | 0.0552 mL | 0.276 mL | 0.5519 mL | 1.1038 mL | 1.3798 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 苹果酸 4-甲酯; Malic acid 4-Me ester | CFN97130 | 66178-02-7 | C5H8O5 = 148.1 | 5mg | QQ客服:2056216494 |
| 2,16-贝壳杉烷二醇; 2,16-Kauranediol | CFN98448 | 34302-37-9 | C20H34O2 = 306.5 | 5mg | QQ客服:2056216494 |
| Calystegine A3; Calystegine A3 | CFN00166 | 131580-36-4 | C7H13NO3 = 159.18 | 5mg | QQ客服:1457312923 |
| Niazirin; Niazirin | CFN96998 | 122001-32-5 | C14H17NO5 = 279.29 | 5mg | QQ客服:3257982914 |